NDC product
Com-Pare2 Flu Relief
NDC 17312-179 · TRP Company
Key facts
| Product NDC | 17312-179 |
|---|---|
| Proprietary name | Com-Pare2 Flu Relief |
| Nonproprietary name | Anas barbariae |
| Substances | CAIRINA MOSCHATA HEART/LIVER AUTOLYSATE |
| Dosage form | TABLET |
| Route | ORAL |
| Labeler | TRP Company |
| Product type | HUMAN OTC DRUG |
| Marketing category | UNAPPROVED HOMEOPATHIC |
| Marketing start | Feb 15, 2021 |
| Listing certified through | Dec 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: